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NailAbstract Objective: The study aimed at assessment of ultrasound (US) in diagnosing nail psori-
asis and onychomycosis.
Methods: One hundred subjects were included: the psoriatic patients group (n= 25), the ony-
chomycosis patients group (n= 25) and the control group (n= 50). Nail psoriasis severity index
(NAPSI) score and onychomycosis severity index were used to assess the patients, in addition to
performing nail culture. The thickness of right index and thumb nail plate (NP) and nail bed
(NB) was measured by US. The following parameters were also assessed: contour and echogenicity
of the NP, NB focal lesions, interpolate space, distal interphalangeal joint (DIJ) changes, proximal
nail fold (PNF) changes and distance between proximal NP and DIJ.
Results: Thumb NP thickness in psoriasis, onychomycosis and control groups was 0.80 ± 0.14 mm
and 0.77 ± 0.21 mm, and 0.61 ± 0.09 mm respectively. The thumb NB thickness in psoriasis, ony-
chomycosis and control groups was 2.05 ± 0.32 mm, 2.13 ± 0.32 mm, and 1.79 ± 0.23 mm respec-
tively. Psoriatic nails show preserved interplate space and DIJ changes. Onychomycotic nails show
loss of interplate space proximally, swollen PNF and decreased Plate/DIJ distance.
Conclusion: US nail measurements and characters can differentiate between psoriasis and ony-
chomycosis.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Psoriasis is a complex, chronic, multifactorial, inﬂammatory
disease involving hyperproliferation of the keratinocytes, with
increased epidermal cell turnover. The diagnosis is clinical, and
the type of psoriasis present affects the physical examination
ﬁndings.
734 S.M. Ally Essayed et al.Chronic stationary psoriasis (psoriasis vulgaris) is the most
common type. It involves the scalp, extensor surfaces, genitals,
umbilicus, and lumbosacral and retroauricular regions, seen as
raised, inﬂamed lesions covered with a silvery white scale. The
scale can be scraped away revealing inﬂamed skin beneath.
Other common types of psoriasis include: Guttate psoriasis,
Inverse psoriasis, Pustular psoriasis, Erythrodermic psoriasis,
Scalp psoriasis, Nail psoriasis, Oral psoriasis, Eruptive psoria-
sis and Psoriatic arthritis which affects about 10–30% of
patients with skin symptoms, occurring in the hands, feet
and large joints (1).
Nail psoriasis is traditionally investigated and diagnosed
clinically. Nails can be affected in 15–50% of patients with
psoriasis and the lifetime incidence of nail involvement reaches
80–90% of psoriasis patients (2). Noninvasive assessment is of
special interest in nail disorders because it may facilitate differ-
ential diagnosis. The thickness of the ﬁnger NP and NB mea-
sured by US is signiﬁcantly higher in patients with psoriasis
compared to healthy controls and patients with chronic
eczema. Increased NP thickness was observed also in patients
with psoriasis without clinically apparent nail involvement (3).
Onychomycosis is a fungal infection of the toenails or ﬁnger-
nails that involves any component of the nail, including the
matrix, NB, or NP. Onychomycosis causes pain, discomfort,
and disﬁgurement and can produce signiﬁcant physical and
occupational limitations, as well as affecting the quality of life.
It has 5 main subtypes: Distal lateral subungual onychomy-
cosis, white superﬁcial onychomycosis, Proximal subungual
onychomycosis, Endonyx onychomycosis, and Candidal ony-
chomycosis. Total dystrophic onychomycosis, the most
advanced form, presents as a thickened, opaque, and yellow-
brown nail (4).
Approximately 50% of all nail abnormalities are caused by
onychomycosis (5). The techniques that are used nowadays to
diagnose nail fungal infections such as potassium hydroxide
(KOH) preparation, culture, biopsy stained by periodic acid–
Schiff, and calcoﬂuor white stain can only provide indirect evi-
dence of a fungal cause.
This study was conducted in an attempt to ﬁnd criteria
which may help in the diagnosis and assessment of severity
of the nail changes in psoriasis and onychomycosis by US.2. Materials and methods
The study is a cross-sectional study, carried out in the Suez
Canal University Hospital, Ismailia, Egypt. The study
included 25 adult patients with psoriasis vulgaris, 25 patients
with onychomycosis and 50 healthy controls. All subjects were
aged >18 years. Patients with psoriasis and onychomycosis
were recruited from patients attending the outpatients’ clinics
of the Dermatology Department of the Suez Canal
University Hospitals, Ismailia, Egypt (the only dermatological
referral center in the Canal region) during the period from
January to November 2013. Healthy controls were the part-
ners or relatives of the patients not affected by psoriasis or
onychomycosis or any other skin or nail condition. The inclu-
sion criteria for cases were a clinical diagnosis of moderate to
severe chronic plaque psoriasis (i.e., lasting at least 6 months);
the absence of systemic or topical anti-psoriatic treatments for
at least 3 months before study inclusion, and patients affected
by onychomycosis in both thumb and index for at least6 months. Patients with eczema localized around the nail folds
were not included. Patients with other types of psoriasis (gut-
tate, erythrodermic and pustular psoriasis), those with con-
comitant diabetes mellitus, inﬂammatory bowel diseases (i.e.,
Crohn’s disease and ulcerative colitis) and those receiving ther-
apeutic interventions that might have inﬂuenced nail status,
including amino-acidic supplements were excluded. The study
was approved by the local ethical committee.
2.1. Clinical evaluation
All subjects were interviewed and examined to collect age, gen-
der, body mass index and smoking habit. Current smokers were
deﬁned as participants who smoked cigarettes daily or who had
stopped smoking <5 years before the enrollment in the study.
Psoriasis-related variables included disease duration and nail
involvement according to the NAPSI (6). The number of ﬁnger
nails affected by psoriasis and the presence of pitting, onychol-
ysis, salmon patches, sub-ungual hyperkeratosis, thickening of
the NP and splinter haemorrhages were clinically assessed.
Onychomycosis-related variables included disease duration
and nail involvement according to onychomycosis severity
index (7), also number of ﬁnger nails affected by onychomyco-
sis and the presence of sub-ungual hyperkeratosis, dermato-
phytoma, slow rate of nail growth, onycholysis and matrix
involvement were clinically assessed. Cases and controls using
drugs or supplements affecting nails status were excluded.
2.2. Nail culture
Nail samples were obtained from pulverized nail scrapings or
clippings with a sterile nail clipper after disinfecting the nail
with 70% alcohol, while the patient has abstained from anti-
fungal medication for at least 3 months. Samples were
obtained from the proximal portion of the nail. To harvest
the invasive front of an onychomycosis, the overlying NP
was removed and samples were taken from the most proximal
portion of the infected NB.
The nail samples collected were transported in a sterile
pouch to microbiology laboratory.
Nail samples were inoculated onto Sabouraud’s dextrose
agar and incubating at 25–28 C and examined daily for
4 weeks.
To avoid overgrowth by nondermatophytes and bacteria,
this medium was modiﬁed by the addition of antibacterial
agents (chlortetracycline and gentamicin) and a mold inhibitor
(cycloheximide).
Growth of non-dermatophytic molds in culture was consid-
ered signiﬁcant only if ‘‘simple association’’ evaluation crite-
rion was met, i.e., non-dermatophytic fungal outgrowth was
considered etiologic whenever direct microscopy was positive
for fungal elements and no dermatophyte could be cultured
from the initial specimen.
Conﬁrmation of Candida species required positive culture
and observation of pseudomycelium under light microscopy
with 20% KOH (8).
2.3. US
US was performed by a single radiologist (author), using
Philips HD 7 Ultrasound System with linear 10–15 MHz
Fig. 1 Clinical signs of psoriasis patients’ nails.
Fig. 2 Clinical signs of onychomycosis patients’ nails.
Nail US in psoriasis and onychomycosis 735probe. The examination required a variable degree of illumina-
tion in the room, thus strong lighting was used for inspecting
the lesion, and a dimmer that allows the room to be darkened
during the US scan. The radiologist was blinded, i.e., he was
not aware if the patient is a control, having psoriasis or ony-
chomycosis. The Rt. thumb and index were preferred for scan-
ning to standardize the procedure.
The US transducer was gently placed over the nail with the
transducer directed perpendicular to the surface with large
amount of gel applied to the examined area to provide a cor-
rect acoustic interface. The nails were scanned with the patient
seated with the hands in pronation; a pad was used to support
the ﬁngers.
The dorsal and ventral aspects of the NP were viewed as
bilaminar, hyperechoic (white), parallel bands with a virtual
hypoechoic (dark gray) space between them called the inter-
plate space. The NB appeared as the hypoechoic region under
the plate, and the nail matrix was the echoic (soft gray) region
at the proximal end of the NB, with no DIJ changes.
The following parameters were evaluated in right thumb
and index of all subjects:
 Ventral and dorsal NP contours.
 Interplate space.
 The thickness of NP and NB was measured in longitudinal
US view (NP thickness is the distance between the superﬁ-
cial surface of the dorsal plate and the deep surface of the
ventral plate). The NB thickness is the distance between
the ventral NP and the cortical surface of the distal
phalanx.
 NP echogenicity and NB focal lesions.
 Matrix thickness and length, distal phalanx periosteal sur-
face, DIJ space and contour, and distance between proxi-
mal NP and DIJ.
 Assessment of PNF thickness.
Every measurement was repeated three times and the mean
value was used for the study.
3. Theory/calculation
It is hypothesized that US can differentiate between ony-
chomycosis and psoriasis by assessing NP thickness, contour,
interpolate changes, PNF thickness as well as arthritic changes
of the DIJ.
4. Results
Table 1 shows the characteristics of the study population.
There was no statistically signiﬁcant difference in age distribu-
tion among studied groups. The age of psoriasis patientsTable 1 The characteristics of the study population.
Psoriasis (n= 25) Onychom
Age {mean ± SD} 44.4 ± 15.4 36.4 ± 12
Gender {No. (%)}
Male 11 (44) 3 (12)
Female 14 (56) 22 (88)ranged from 19 to 67 years, the age of the onychomycosis
patients ranged from 18 to 58 years, while the age of normal
healthy controls ranged from 18 to 59 years old. Twenty two
patients (88%) with onychomycosis were females, while only
14 (56%) of psoriasis patients and 26 (52%) of controls were
females. Fourteen (56%) psoriasis patients, 9 (36%) ony-
chomycosis patients and 24 (48%) of controls were not manual
workers.
The mean duration of psoriasis was 44.4 ± 15.4 months,
and the mean NAPSI score was 27.4 ± 4.3. There were statis-
tically signiﬁcant positive correlation between NAPSI score
and duration of the disease (r= 0.665, p-value = 0.000).
Nineteen (76%) of the psoriatic patients show clinical evi-
dences of nail affection. The most common signs of psoriasis
nail affection were onycholysis, subungual hyperkeratosis,
and nail pitting (Fig. 1).
Yeast was the causative organism in 60% of onychomycosis
patients. Subungual hyperkeratosis, dermatophytoma and
onycholysis were the most common nail signs (Fig. 2).ycosis (n= 25) Controls (n= 50) p-Value
.4 38.8 ± 9.7 0.055
24 (48) 0.005
26 (52)
Fig. 5 US image (longitudinal view) of the thumb in a 67 year
old psoriasis male patient showing irregular plates contour and
DIJ erosions. Interplate space is preserved. PNF is normal. (NP
thickness = 1.1 mm and NB thickness = 2.2 mm).
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group was seen as follows: The DP and VP were seen as sharp
smooth hyperechoic parallel lines with the hypoechoic interpo-
late space in between. The NB appeared as a hypoechoic zone
indistinguishable from the subcutaneous tissues. The cortical
outline of the distal phalanx appeared as sharp hyperechoic
line under the NB. The epidermis appeared as an echogenic
thin regular line. The dermis is a less echogenic line, while
the subcutaneous fat is hypoechoic and separated by echogenic
ﬁbrous septa (Figs. 3 and 4) (9).
The NP contour irregularity was signiﬁcantly higher in 24
(96%) of onychomycosis patients compared to psoriasis
patients. None of the control subjects showed NP contour
irregularity. Interplate space was lost proximally in about half
onychomycosis patients. A 44% of psoriasis patients showed
DIJ synovitis and erosions. A 7 (28%) of the psoriatic patients
had DIJ arthritis detected by US. Swollen PNF was found in
11 (44%) onychomycosis patients compared to none in psori-
asis patients and the control group (Figs. 5–8) (see Tables 2
and 3).
The NP thickness, NB thickness and plate/DIJ distance
were signiﬁcantly different among the three study groups
(Tables 4 and 5). The cut-off values of 0.63 mm andFig. 4 US image (longitudinal view) of the index in a normal
39 year old male (control group) showing regular plates contours,
preserved interplate space, normal DIJ and PNF, (NP thick-
ness = 0.61 mm and NB thickness = 1.46 mm).
Fig. 6 US image (longitudinal view) of the thumb in a 49 year
old onychomycosis male patient showing irregular plates con-
tours, lost interplate space proximally, normal DIJ and swollen
PNF, (NP thickness = 0.71 mm and NB thickness = 2.78 mm).
Fig. 3 US image (longitudinal view) of the thumb in a normal
26 year old male (control group) showing regular plates contour,
preserved interplate space, normal DIJ and PNF, (NP thick-
ness = 0.61 mm and NB thickness = 1.88 mm).
Fig. 7 US image (longitudinal view) of the index ﬁnger in a
52 year old psoriasis male patient showing regular plates contour
proximally, preserved interplate space, DIJ erosions and normal
PNF, (NP thickness = 1.00 mm and NB thickness = 2.1 mm).
Fig. 8 US image (longitudinal view) of the index ﬁnger in a
22 year old male onychomycosis patient showing irregular plates
contours, lost interplate space lost, normal DIJ and swollen PNF,
(NP thickness = 0.66 mm and NB thickness = 2.18 mm).
Table 3 Index US characters of psoriasis (n= 25), onycho-
mycosis (n= 25), and control groups (n= 50).
Index Psoriasis
no. (%)
Onychomycosis
no. (%)
Control
no. (%)
p-Value
DP contour
Normal 7 (28) 2 (8) 50 (100) 0.00
Irregular 18 (72) 23 (92) 0 (0)
VP contour
Normal 7 (28) 1 (4) 50 (100) 0.00
Irregular 18 (72) 24 (96) 0 (0)
Interplate space
Normal 20 (80) 7 (28) 50 (100) 0.00
Lost proximally 0 (0) 12 (48) 0 (0)
Lost distally 2 (8) 1 (4) 0 (0)
Lost totally 3 (12) 2 (8) 0 (0)
Decreased thickness 0 (0) 3 (12) 0 (0)
DIJ changes
Synovitis 6 (24) 0 (0) 0 (0) 0.00
None synovitis 18 (72) 25 (100) 50 (10)
Synovitis & erosion 1 (4) 0 (0) 0 (0)
Swollen PNF
Present 0 (0) 13 (52) 0 (0) 0.00
Absent 25 (100) 12 (48) 50 (100)
Table 2 Thumb US characters of psoriasis (n= 25),
onychomycosis (n= 25), and control groups (n= 50).
Thumb Psoriasis
no. (%)
Onychomycosis
no. (%)
Control
no. (%)
p-Value
DP contour
Normal 7 (28) 1 (4) 50 (100) 0.00
Irregular 18 (72) 24 (96) 0 (0)
VP contour
Normal 7 (28) 1 (4) 50 (100) 0.00
Irregular 18 (72) 24 (96) 0 (0)
Interplate space
Normal 17 (68) 7 (28) 50 (100) 0.00
Lost proximally 1 (4) 12 (48) 0 (0)
Lost distally 4 (16) 2 (8) 0 (0)
Lost totally 3 (12) 3 (12) 0 (0)
Decreased thickness 0 (0) 1 (4) 0 (0)
DIJ changes
Synovitis 6 (24) 0 (0) 0 (0) 0.00
None synovitis 18 (72) 25 (100) 50 (100)
Synovitis & erosion 1 (4) 0 (0) 0 (0)
Swollen PNF
Present 0 (0) 11 (44) 0 (0) 0.00
Absent 25 (100) 56) 50 (100)
Table 5 US measurements of the index ﬁnger.
Psoriasis
mean (SD)
Onychomycosis
mean (SD)
Control
mean (SD)
p-Value
Index NP
thickness
0.67 ± 0.14 0.68 ± 0.16 0.54 ± 0.08 0.000
Index NB
thickness
2.01 ± 0.40 2.06 ± 0.47 1.75 ± 0.26 0.002
Index
matrix
thickness
2.08 ± 0.34 1.99 ± 0.38 1.91 ± 0.34 0.121
Index
Plate/DIP
distance
0.91 ± 0.22 0.79 ± 0.17 0.94 ± 0.11 0.001
Table 4 US measurements of the thumb ﬁnger.
Psoriasis
mean (SD)
Onychomycosis
mean (SD)
Control
mean (SD)
p-Value
Thumb NP
thickness
0.80 ± 0.14 0.77 ± 0.21 0.61 ± 0.09 0.000
Thumb NB
thickness
2.05 ± 0.32 2.13 ± 0.32 1.79 ± 0.23 0.000
Thumb
matrix
thickness
2.08 ± 0.37 1.93 ± 0.45 1.98 ± 0.39 0.386
Thumb
plate/DIJ
distance
1.18 ± 0.24 0.99 ± 0.15 1.20 ± 0.16 0.000
Nail US in psoriasis and onychomycosis 7370.61 mm for the thickness of thumb and index NP were found
to be 84% accurate and statistically signiﬁcant in diagnosing
psoriatic nail affection with a sensitivity of (72%, 60%) and
speciﬁcity of (70%, 88%) respectively. A thumb NB thickness
>1.85 mm can discriminate patients with psoriatic nails with
an accuracy, sensitivity, speciﬁcity of 73%, 64% and 72%
respectively. An index ﬁnger NB thickness >1.89 mm can dis-
criminate patients with psoriasis with an accuracy sensitivity,
speciﬁcity of 71%, 64% and 34% respectively.
There were positive correlations between thumb NP thick-
ness with age and duration of disease (r= 0.464, 0.574 and
P= 0.019, 0.003), respectively. There were signiﬁcant correla-
tions between thumb NP thickness with duration of the disease
and onychomycosis severity index (r= 0.361, 0.735 and
738 S.M. Ally Essayed et al.P= 0.077, 0.000), respectively. The relation between index NP
thickness and onychomycosis severity index was also found to
be signiﬁcant (r= 0.536 and P= 0.006).
In onychomycosis group, there was no statistically signiﬁ-
cant difference between different causative organisms regard-
ing thumb and index mean NP thickness (p-value 0.662 and
0.187 respectively).
5. Discussion
The mean thumb NP thickness in the control group differs
from Wollina et al. and Mogensen et al. who reported a thin-
ner thumb NP thickness than present in our results. This dif-
ference may be due to ethnic variations (10,11).
DIP changes by US were found in 28% of psoriatic patients
while none of the other groups showed DIP abnormalities.
Aydin et al. found extensor tendon enthesopathy by US as
focal thickening in patients with psoriasis (12).
To the best of our knowledge, this is the ﬁrst study which
describes matrix thickness and plate/DIP distance. However,
Wollina et al. calculated nail volume and matrix volume in
healthy volunteers and in nail disease, and found characteristic
quantitative changes in diseased nails in these parameters (10).
This study shows that nail involvement was very frequent in
patients with chronic plaque psoriasis, involving 19 (76%) pso-
riatic patients. This ﬁnding is close to that of Gisondi et al. as
73% of his patients had nail involvement (3). On the other
hand, nails involvement were less frequent than we reported
in Augustin et al., Baran and Armesto et al. which were
40.9%, 50% and 47.4% respectively (13–15).
Psoriatic arthritis was detected by US in 7 (28%) patients.
Augustin et al. and Armesto et al. reported a higher incidence
of 38% and 41.2% respectively (13,15). Aydin et al. found US
nail changes in 33.9% of psoriatic patients (16).
NAPSI scores were (24.12 ± 19.78) in this study, while
Gisondi et al. reported that nail Psoriasis scores
(18.4 ± 17.5) which are lower than ours (3).
Onycholysis and thickening of the NP were the most com-
mon nail signs of nail psoriasis whereas pitting and splinter
haemorrhages were the least common. Our ﬁndings are also
consistent with those reported by Brazzelli et al. and Gisondi
et al. (17,3).
US detected NP contour irregularity in 18 (72%) of the
psoriasis patients. The interplate space was preserved in 17
patients (68%). DIJ changes indicating presence of arthritis
were present in 6 and 7 (24% and 28%) thumb and index
cases, respectively. Wollina et al. found no special pattern of
nail in psoriasis patients by US (18).
The thickness of the NP and NB was found to be higher in
patients with psoriasis with nail involvement and even in
patients without clinically apparent nail psoriasis compared
to healthy controls. The mean NP thickness in psoriasis
patients with nail changes was higher than the mean NP thick-
ness in patients without nail changes, but this difference was
not statistically signiﬁcant. Our ﬁndings are also consistent
with those reported by Gisondi et al. (3).
Wortsman et al. described 4 types of US changes in psoriatic
nails: focal hyperechoic involvement of the ventral plate with-
out involvement of the dorsal plate (type I), loosening of the
borders of the ventral plate (type II), appearance of wavy plates
(type III) and loss of deﬁnition on both plates (type IV) (19).Thickness of thumb and index NP over 0.63 mm and
0.61 mm was found to have (72%, 60%) sensitivity, (70%,
88%) speciﬁcity; and for thumb and index. NB thickness over
1.85 mm and 1.89 mm was found to have (64%, 64%) sensitiv-
ity, (72%, 34%) speciﬁcity, respectively. This was expected,
because nail psoriasis affecting the lamina and/or the matrix
easily induce an increased thickness of these structures.
Wortsman et al. and Gisondi et al. have made similar observa-
tions (19,3). Sandobal et al. found a NB thickness of 2 mm as a
cutoff value to differentiate between psoriatic patients and the
normal population (20).
US for patients with onychomycosis revealed involvement
of both plates in 24 (96%) patients. Interplate space was lost
proximally in 12 (48%) patients. No DIJ changes observed
in this group. Wollina et al. found no special pattern of nails
by US among onychomycosis patients (18). The use of US
opens the possibility of monitoring disease progression or
treatment. Wortsman and Jemec found diffuse thickening of
the NP among onychomycosis patients as in psoriasis; how-
ever, these can merge in one thick plate in fungal involvement
of the nail unit producing a signiﬁcant increase in the thickness
of the NB greater than that observed with nail psoriasis (21).
In conclusion, US can improve diagnostic precision
together with clinical examination and avoid disadvantages
of invasive nail investigations such as nail biopsies which are
associated with unacceptable pain and cosmetics sequels as
well as long waiting periods for obtaining results. US assess-
ment of thickness of NP and NB as well as morphology can
help discriminating psoriasis and onychomycosis patients.
Psoriatic nails show preserved interplate space and DIJ
changes with occasional presence of DIJ changes.
Onychomycosis nails show loss of interplate space proximally,
swollen PNF and decreased Plate/DIJ distance.Conﬂict of interest
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